Business
Disclosure of transparency notifications from BlackRock, Inc.
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 18 May 2026 – 6 PM CET Disclosure of transparency notifications from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of major shareholdings in listed companies, Fagron received two transparency notifications from BlackRock, Inc., dated 13 May 2026. Notifications from BlackRock, Inc. On 13 and 14 May 2026, Fagron received two transparency notifications from BlackRock, Inc.: In the first notification,
About this update from Blackrock, Inc.
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 18 May 2026 – 6 PM CET Disclosure of transparency notifications from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of major shareholdings in listed companies, Fagron received two transparency notifications from BlackRock, Inc., dated 13 May 2026. Notifications from BlackRock, Inc. 220,504 shares held through BlackRock Advisors (UK) Limited, 41,249 shares held through BlackRock Asset Management Canada Limited, 4 shares held through BlackRock Financial Management, Inc., 1,112,264 shares held by BlackRock Fund Advisors, 643,198 shares held by BlackRock Institutional Trust Company, National Association, 193 shares held by BlackRock Investment Management (Australia) Limited, 54,676 shares held by BlackRock Investment Management (UK) Limited and 100 shares held by BlackRock Investment Management, LLC. The total number of 2,072,188 shares corresponds to the same number of voting rights. 3,371 contracts held by BlackRock Advisors (UK) Limited, 3,244 contracts held by BlackRock Investment Management (UK) Limited, 696 contracts held by BlackRock Investment Management, LLC, 62,729 contracts held by BlackRock Advisors, LLC, 56,007 contracts held by BlackRock Financial Management, Inc., 9,242 contracts held by BlackRock Institutional Trust Company, National Association and 9,741 contracts held by BlackRock Investment Management (UK) Limited. The total number of 145,030 equivalent financial instruments corresponds to the same number of voting rights. 180,410 shares held through BlackRock Advisors (UK) Limited, 41,249 shares held through BlackRock Asset Management Canada Limited, 4 shares held through BlackRock Financial Management, Inc., 1,112,264 shares held by BlackRock Fund Advisors, 643,242 shares held by BlackRock Institutional Trust Company, National Association, 193 shares held by BlackRock Investment Management (Australia) Limited, 12,939 shares held by BlackRock Investment Management (UK) Limited and 100 shares held by BlackRock Investment Management, LLC. The total number of 1,990,401 shares corresponds to the same number of voting rights. 3,371 contracts held by BlackRock Advisors (UK) Limited, 3,244 contracts held by BlackRock Investment Management (UK) Limited, 696 contracts held by BlackRock Investment Management, LLC, 62,729 contracts held by BlackRock Advisors, LLC, 56,007 contracts held by BlackRock Financial Management, Inc., 9,242 contracts held by BlackRock Institutional Trust Company, National Association and 9,741 contracts held by BlackRock Investment Management (UK) Limited. The total number of 145,030 equivalent financial instruments corresponds to the same number of voting rights. Further information Ignacio Artola Global Head of Investor Relations [email protected] About Fagron Fagron is the leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics, and patients in more than 38 countries around the world. The Belgian company Fagron NV is based in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed through the Dutch company Fagron BV with head office in Rotterdam. Important information regarding forward-looking statements Certain statements in this press release may be deemed to be forward-looking. Such forward-looking statements are based on current expectations and are influenced by various risks and uncertainties. Consequently, Fagron cannot provide any guarantee that such forward-looking statements will, in fact, materialize and cannot accept any obligation to update or revise any forward-looking statement as a result of new information, future events or for any other reason. In the event of differences between the English translation and the Dutch original of this press release, the latter prevails. Attachment